Research > Tumour Microcirculation Group > Publications
2005 2004 2003 2002 2001 2000 1999 1998 1997 1995
Gillian M. Tozer, Chryso Kanthou & Bruce C. Baguley, DISRUPTING TUMOUR BLOOD VESSELS, Nature Reviews Cancer (5), 423-435 (2005)
Cemazar, M., Wilson, I., Prise, V. E., Bell, K. M., Hill, S. A. and Tozer, G. M. The endothelin B (ETB) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification Br J Cancer , in press (2005).
Dachs, G.U., Tupper J. and Tozer, G.M., From bench to bedside for gene-directed enzyme prodrug therapy of cancer, Anticancer Drugs, 16: 349-359 (2005).
O. Greco, T. Powell, B. Marples, M.C. Joiner and S.D. Scott. Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin. Cancer Gene Ther . In press (2005)
O. Greco, M.C. Joiner, A. Doleh and S.D. Scott. VP22: intercellular transport for suicide gene therapy under oxic and hypoxic conditions. Gene Therapy. In press (2005)
N. Chadderton, R.L. Cowen, S. Robinson, O. Greco, S.D. Scott, I.J. Stratford, A.V. Patterson and K.J. Williams. Dual responsive promoters to target therapeutic gene expression to radiation-resistant hypoxic tumour cells. Int. J. Radiat. Oncol. Biol. Phy s. In press (2005)
Leach, M. O., Brindle, K. M., Evelhoch, J. L., Griffiths J. R., Horsman M. R., Jackson, A., Jayson G, C., Judson, I. R., Knopp M, V., Maxwell R. J., McIntyre D., Padhani, A. R., Price, P., Rathbone, R., Rustin, G. J., Tofts, P. S., Tozer , G. M., Vennart, W., Waterton, J. C., Williams, S. R. and Workman, P; Pharmacodynamic/Pharmacokinetic Technologies Advisory Committee, Drug Development Office, Cancer Research UK. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer , 92: 1599-610 (2005).
B. Marples, O. Greco, M.C. Joiner and S.D. Scott. Radiogenetic therapy using radiation- responsive promoters. Front. Med. Chem. 2: 317-330 (2005)
Sonveaux, P., Kaz, A. M., Snyder, S. A., Richardson, R. A., Cardenas-Navia, L. I., Braun, R. D., Pawloski J. R., Tozer, G. M., Bonaventura, J., McMahon, T. J., Stamler, J. S., Dewhirst, M. W. Oxygen regulation of tumor perfusion by S-nitrosohemoglobin reveals a pressor activity of nitric oxide. Circ Res, 96:1119-1126 (2005).
Tozer, G.M., Ameer-Beg, S.M., Baker, J., Barber, P.R., Hill, S.A., Hodgkiss, R.J., Locke, R.J., Prise, V.E., Wilson, I. and Vojnovic, B. Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy. Adv Drug Deliv Rev , 57: 135-152 (2005).
Tozer, G.M., Kanthou, C. and Baguley, B. C., 2005, Disrupting tumour blood vessels: combretastatins, DMXAA and other low molecular weight drugs, Nature Reviews Cancer , 5: 423-435 (2005).
Cemazar, M., Wilson, I., Dachs, G.U., Tozer, G.M. and Sersa G. Direct visualization of electroporation-assisted in vivo gene delivery to tumors using intravital microscopy - spatial and time dependent distribution. BioMed Central Cancer, 4: 81-87 (2004).
Dachs, G.U., Greco, O. and Tozer, G.M. Targeting cancer with gene therapy using hypoxia as a stimulus. Methods Mol Med, 90: 371-387 (2004).
Kanthou, C., Greco, O., Stratford, A., Cook, I., Knight, R., Benzakour, O. and Tozer, G. The tubulin-binding agent combretastatin A-4-phosphate arrests endothelial cells in mitosis and induces mitotic cell death. Am J Pathol, 165: 1401-1411 (2004).
Reyes-Aldasoro, C. C, A Guide to Co-occurrence Matrix Analysis, Research Report CS-RR-398, Computer Science Research Reports, University Warwick, UK, February 19, 2004.
S.D. Scott and O. Greco. Radiation and hypoxia inducible gene therapy systems. Cancer Metastasis Rev . 23: 269-276 (2004)
Tozer, G. M. and Bicknell, R. Therapeutic Targeting of the Tumour Vasculature, Semin. Radiat. Oncol., Semin Radiat Oncol, 14: 222-232 (2004).
Tupper, J., Tozer, G. M. and Dachs, G. U. Use of horseradish peroxidase for gene-directed enzyme prodrug therapy with paracetamol. Br J Cancer , 90: 1858-1862 (2004).
Tupper, J., Greco, O., Tozer, G. M. and Dachs, G. U. Analysis of the horseradish peroxidase / indole-3-acetic acid combination in a three dimensional tumour model. Cancer Gene Therapy, 11: 508-513 (2004).
A. Bhalerao and C.C. Reyes-Aldasoro, Selecting Discriminant Subbands for Texture Classification, Proceedings of Eurocast'03, February 2003, Canarias, Spain
Barber, P. R., Vojnovic, B. Ameer-Beg, S. M., Hodgkiss, R. J., Tozer, G. M., and Wilson, J. Semi-Automated Software for the 3D Delineation of Complex Vascular Networks. J. Microscopy, 211: 54-62 (2003).
Brooks, A. C., Kanthou, C., Cook I.H., Tozer, G.M, Barber, P.R., Vojnovic, B., Nash, G.B. and Parkins, C.S. The vascular targeting agent combretastatin A-4-phosphate induces neutrophil recruitment to endothelial cells in vitro . Anticancer Research, 23: 3199-3206 (2003).
Brooks, A. C., Kanthou, C., Cook I.H., Nash, G.E., Tozer, G.M, Barber, P.R., Vojnovic, B. and Parkins, C.S. In vitro neutrophil recruitment to combretastatin A-4-phosphate treated endothelial cells under conditions of flow (Anticancer Res, in press)
M. Durante, G. Snigiryova, E. Akaeva, A. Bogomazova, S. Druzhinin, B. Fedorenko, O. Greco, N. Novitskaya, A. Rubanovich, V. Shevchenko, U. von Recklinghausen and G. Obe. Chromosome aberration dosimetry in cosmonauts after single or multiple space flights. Cytogenet. Genome Res . 103: 40-46 (2003)
Galbraith, S. M., Maxwell, R. J., Lodge, M. A., Tozer, G. M., Wilson, J., Taylor, N. J., Stirling, J., Sena, L., Padhani, A. R. and Rustin, G. J. S. Combretastatin A4 phosphate has tumour antivascular activity in rat and man, as demonstrated by dynamic magnetic resonance imaging. J Clin Oncol. 21: 2831-2842 (2003).
O. Greco, M. Durante, G. Gialanella, G. Grossi, M. Pugliese, P. Scampoli, G. Snigyriova and G. Obe. Biological dosimetry in Russian and Italian astronauts. Adv. Space Res . 31: 1495-1503 (2003)
Khelifi, A.F., Prise, V.E. and Tozer, G.M., 2002. Effects of tin-protoporphyrin IX on blood flow in a rat tumour model. Experimental Biology and Medicine, 228:481-485 (2003).
O. Greco, B. Marples, M.C. Joiner and S.D. Scott. How to overcome (and exploit) tumor hypoxia for targeted gene therapy. J. Cell. Physiol. 197: 312-325 (2003)
Leach, M.O., Brindle, K.M., Evelhoch, J.L., Griffiths, J.R., Horsman, M.R., Jackson, A., Jayson, G., Judson, I.R., Knopp, M.V., Maxwell, R.J., McIntyre, D., Padhani, A.R., Price, P., Rathbone, R., Rustin, G., Tofts, P.S., Tozer, G.M., Vennart, W., Waterton, J.C., Williams, S.R. and Workman, P., 2003, Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials. Br J Radiol , 76: S87-91 (2003).
B. Marples, O. Greco, M.C. Joiner and S.D. Scott. Radiogenetic therapy: strategies to overcome tumour resistance Molecular approaches to chemo-radiotherapy. Curr. Pharm. Des . 9: 2105-2112 (2003)
A.V. Patterson, M.P. Saunders and O. Greco. Prodrugs in genetic chemotherapy. Curr. Pharm. Des . 9: 2131-2154 (2003)
Reyes-Aldasoro, C. C. and Bhalerao, A., Volumetric Texture Description and Discriminant Feature Selection for MRI, Information Processing in Medical Imaging, Ambleside, Lake District, UK, 21-25 July, 2003, pp. 282-293.
Tozer, G. M. Measuring tumour vascular response to anti-vascular and anti-angiogenic drugs. Br J Radiol , 76: S23-S35 (2003).
Brooks, A.C., Nash, G.E., Parkins, C.S. and Tozer, G. M. Neutrophil-endothelial interactions following endothelial pre-conditioning by the breast carcinoma cell line, MDA-MB-231. Proceedings of the 22nd Meeting of the European Society for Microcirculation , Monduzzi Editore S.p.A. - Medimond Inc., pp 13-17 (2002).
Cemazar, M., Sersa, G., Wilson, J., Tozer, G. M., Hart, S. L., Grosel, A. and Dachs, G. U. Effective gene transfer to solid tumours using different non-viral delivery techniques; electroporation, liposomes and integrin-targeted vector. Cancer Gene Therapy , 9: 399-406 (2002).
Dachs, G.U., Kanthou, C. and Tozer, G. M. Effect of radiation and combretastatin A-4-P on cellular localisationof hypoxia inducible factor 1. Proceedings of the 22nd Meeting of the European Society for Microcirculation , Monduzzi Editore S.p.A. - Medimond Inc., pp 19-23 (2002).
Davis P. D., Dougherty G. J., Blakey D. C., Galbraith S. M., Tozer G. M., Holder A. L., Naylor M. A., Nolan J., Stratford M. R., Chaplin D. J. and Hill S. A. ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature. Cancer Research, 62: 7247-53 (2002).
Davis, P. D., Tozer, G.M., Naylor, M.A., Thomson, P., Lewis, G. and Hill, S.A. Enhancement of vascular targeting by inhibitors of nitric oxide synthase. Int J Radiat Oncol Biol Phys, 54: 1532-1536 (2002).
Folkes, L. K., Greco, O., Dachs, G. U., Stratford, M. R. L. and Wardman, P., 2002. 5-Fluoroindole-3-acetic acid: a prodrug activated by a peroxidase with potential for use in targeted cancer therapy. Biochem Pharmacol, 63, 265-272.
Greco, O, Scott S. D., Marples B., Dachs, G. U., 2002. Cancer gene therapy: 'DELIVERY, DELIVERY, DELIVERY'. Front Biosci., 7, D1516-24.
Greco O., Tozer, G. M. and Dachs, G. U. Oxic and anoxic enhancement of radiation-mediated toxicity by horseradish peroxidase/indole-3-acetic acid gene therapy. Int J Radiat Biol. , 78: 173-181 (2002).
O. Greco, B. Marples, G.U. Dachs, K.J. Williams, A.V. Patterson and S.D. Scott. Novel chimeric gene promoters responsive to hypoxia and ionizing radiation. Gene Therapy 9: 1403-1411 (2002)
Greco, O., Dachs,G.U., Tozer, G.M. and Kanthou, C. Mechanisms of cytotoxicity induced by horseradish peroxidase / indole-3-acetic acid gene therapy. Journal of Cell Biochem, 87: 221-232 (2002).
O. Greco, G. Obe, G. Gialanella, G. Grossi, M. Horstmann, M. Pugliese, P. Scampoli, U. von Recklinghausen and M. Durante. Chromosome damage in cosmonauts´ lymphocytes detected by FISH painting. Microgr. Space Stat. Utiliz. 3: 11-17 (2002)
Hill, S.A., Tozer, G.M., Pettit, G. R. and Chaplin, D.J. Preclinical evaluation of the antitumour activity of the novel vascular targeting agent Oxi 4503, Anticancer Res, 22: 1453-1458 (2002).
Hill, S.A., Chaplin, D.J., Lewis, G. and Tozer, G.M. Schedule dependence of combretastatin A4 phosphate in transplanted and spontaneous tumour models, Int J Cancer, 102: 70-74 (2002).
anthou, C. and Tozer, G.M. The tumour vascular targeting agent Combretastatin A-4-Phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells. Blood , 99: 2060-2069 (2002).
Khelifi, A. L., Prise, V. E., Foresti, R., Clark, J. E., Kanthou, C., Motterlini, R. and Tozer, G. M.. Heme oxygenase and the novel tumour-specific anti-vascular compound combretastatin A4-phosphate. In: Heme Oxygenase in Biology and Medicine, N. G. Abraham, J. Alam, K. A. Nath, editors ; Kluwer Academic/ Plenum Publishers, pp. 303-312 (2002).
Marples, B., Greco, O., Joiner, M. C., Scott, S. D., 2002. Molecular approaches to chemo-radiotherapy. Eur J Cancer , 38, 231-9.
Maxwell, R. J., Wilson, J., Prise,V. E., Vojnovic, B., Rustin, G. J., Lodge, M. A. and Tozer, G. M. Evaluation of the anti-vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI. NMR in Biomed ., 15: 89-98 (2002).
Parkins, C.S., Cook, I.H., Kanthou, C., Mapp, P.I. and Tozer, G.M. Nitrotyrosination of endothelial alpha-tubulin: potential effects on binding of the tumour vascular-targeting agent, combretastatin A-4-P. Proceedings of the 22nd Meeting of the European Society for Microcirculation , Monduzzi Editore S.p.A. - Medimond Inc., pp 33-37 (2002).
Prise, V.E., Honess, D.J., Stratford, M.R.L., Wilson, J. and Tozer, G.M. The vascular response of tumour and normal tissues in the rat to the vascular targeting agent, combretastation-A4-phosphate, at clinically relevant doses, Int J Oncol, 21: 717-726 (2002)
Reyes-Aldasoro,C. C. and Bhalerao, A. , Volumetric Texture Description and Discriminant Feature Selection for MRI, Volumetric Analysis of MR Images, IPEM Meetings, London, UK, 20 November, 2002.
Reyes-Aldasoro,C. C. and Bhalerao, A., Sub-band filtering for MR Segmentation, Medical Image Understanding and Analysis, Portsmouth, UK, 22-23 July, 2002, pp. 185-188.
Reyes-Aldasoro, C. C., and Bhalerao, A. , Sub-band filtering for MR Segmentation, COST Meeting, Bergen, Norway May 2002.
Seddon, B. M., Maxwell, R. J., Honess, D. J., Grimshaw, R., Raynaud, F., Tozer, G. M. and Workman, P., 2002. Validation of the fluorinated 2-nitroimidazole SR-4554 as a non-invasive hypoxia marker detected by magnetic resonance spectroscopy. Clin Cancer Res , 8: 2323-2335 (2002).
Tozer, G. M., Kanthou, C., Parkins, C. S. and Hill, S. A. The biology of the combretastatins as tumour vascular targeting agents. Int. J. Exp. Pathol ., 83: 21-38 (2002).
Tozer, G. M., Honess, J., Wilson, J., Hill, S. A., Hodgkiss, R. J., Ameer-beg, S., Vojnovic, B. and Prise, V. E. Efficacy of the tumour vascular targeting agent combretastatin A-4-P at clinically relevant doses. Proceedings of the 22nd Meeting of the European Society for Microcirculation , Monduzzi Editore S.p.A. - Medimond Inc., pp 43-47 (2002).
Ameer-Beg, S. M., Barber, P. R., Hodgkiss, R. J., Locke, R. J., Newman, R. G., Tozer, G. M., Vojnovic, B. and Wilson, J.. Application of multiphoton steady state and lifetime imaging to mapping of tumour vascular architecture in vivo. Proceedings SPIE, 4620: 85-95 (2002).
Cemazar, M., Parkins, C. S., Holder, A. L., Chaplin, D. J., Tozer, G. M. and Sersa, G. Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy. British J Cancer ; 84: 565-570 (2001).
Coralli, C., Kanthou, C., Tozer, G. M. and Dachs, G. U. Limitations of the reporter green fluorescent protein under simulated tumour conditions. Cancer Research; 61: 4784-4790 (2001).
Galbraith, S. M., Chaplin, D. J., Lee, F., Locke, R. J., Vojnovic, B. and Tozer, G. M. Effects of combretastatin A4 phosphate on endothelial cell morphology in vitro and relationship to tumour vascular targeting activity in vivo. Anticancer Research; 21: 93-102 (2001).
Greco, O. and Dachs, G.U., 2001. Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives. J Cell Physiol, 187, 22-36.
Greco, O., Rossiter, S., Kanthou, C., Folkes, L. K., Wardman, P., Tozer, G. M. and Dachs, G. U. Horseradish peroxidase-mediated gene therapy: choice of prodrugs in oxic and anoxic tumour conditions. Molecular Cancer Therapeutics, 1: 151-160 (2001).
Ishida, A. Murray, J., Saito, Y., Kanthou, C. Benzakour O, Shibuya, M. and Wijelath E., 2001. Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol, 188, 359-368.
Seddon, B. M., Honess, D. J., Vojnovic, B., Tozer, G. M. and Workman, P. Measurement of tumor oxygenation: in vivo comparison of a luminescence fiber-optic sensor and a polarographic electrode in the P22 tumor. Radiation Research; 155: 837-846 (2001).
Tozer, G. M., Prise, V. E., Wilson, J., Cemazar, M., Shan, S., Dewhirst, M. W., Barber, P. R., Vojnovic, B. and Chaplin, D. J. Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability. Cancer Research; 61; 6413-6422 (2001).
Benzakour O and Kanthou C., 2000. The anti-coagulant factor, protein S, is produced by cultured human vascular smooth muscle cells and its expression is up-regulated by thrombin. Blood , 95, 2008-2014.
Dachs, G.U., Coralli, C., Hart, S.L., and Tozer, G.M., 2000. Gene delivery to hypoxic cells in vitro. Br J Cancer , 83, 662-667.
Dachs, G.U. and Tozer, G.M., 2000. Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. Eur J Cancer , 36, 1649-1660.
Dewhirst, M. W., Tozer, G., Wilson, J., Rosner, G., Lanzen, J., Kaz, A., Snyder, S. and Stamler, J. Modulation of tumour blood flow by nitric oxide. Radiation Research. Volume 2. Congress Proceedings for the 11th International Congress of radiation research, July 18-23, 1999, Dublin, Ireland. pp 610-613. Eds. M. Moriarty, C. Mothershill, C. Seymour, M. Edington, J. F. Ward, R. J. M. Fry. Allen Press, Inc., Lawrence, U.S.A (2000).
Greco, O., Folkes, L.K., Wardman, P., Tozer, G.M., and Dachs, G.U., 2000. Development of a novel enzyme/prodrug combination for gene therapy of cancer: horseradish peroxidase/indole-3-acetic acid. Cancer Gene Therapy , 7, 1414-1420.
Greco, O., Patterson, A.V. and Dachs, G.U., 2000. Can gene therapy overcome the problem of hypoxia in radiotherapy? J Radiat Res (Tokyo) , 41, 201-212.
Kanthou C. and Benzakour O., 2000. Cellular effects and signalling pathways activated by the anti-coagulant factor, protein S, in vascular cells. Adv Exp Med Biol , 476, 155-166.
Maxwell, R. J., Wilson, J., Tozer, G. M., Barber, P. R. and Vojnovic, B. Segmentation of magnetic resonance images according to contrast agent uptake kinetics using a competitive neural nework, pp 93-98, in Artificial neural networks in medicine and biology. Eds. H. Malmgren, M. Borga, L. Niklasson, Springer-Verlag, London (2000).
Parkins, C.S., Holder, A.J., Hill, S.A., Chaplin, D.J. and Tozer, G.M, 2000. Determinants of anti-vascular action by Combretastatin A-4 phosphate: role of nitric oxide. Br J Cancer , 83, 811-816.
Reyes-Aldasoro, Constantino Carlos, Image Segmentation with Kohonen Neural Network Self Organising Maps. International Conference on Telecommunications ICT 2000 May 2000, Acapulco, México.
Reyes-Aldasoro, C. C., and Aldeco A. L., Image Segmentation and Compression using Neural Networks, Advances in Artificial Perception and Robotics CIMAT, Guanajuato, México October 23-25, 2000, Guanajuato, Mexico.
Reyes-Aldasoro CC, Algorri ME, "A combined algorithm for image segmentation using neural networks and 3D surface reconstruction using dynamic meshes", Rev Mex Ing Biomed, (2000); Vol. 21 No. 3, pp. 73-81.
Reyes-Aldasoro, C.C. and Algorri Guzmán, M.E. , A Combined Algorithm for Image Segmentation using Neural Networks and 3D Surface Reconstruction using Dynamic Meshes, V Ibero-american Symposiun on Pattern Recognition, Lisbon, Portugal, September 11-13, 2000.
Bell, K .M., Chaplin, D.J., Poole, B.A., Prise, V.E. and Tozer, G.M., 1999. Modification of blood flow in the HSN tumour and normal tissues of rat by the endothelin ET-B receptor agonist IRL 1620. Int J Cancer , 80, 295-302.
Dunn, T.J., Braun, R.D., Rhemus, W.E., Rosner, G.L., Secomb, T.W., Tozer, G.M., Chaplin, D.J. and Dewhirst, M.W., 1999. The effects of hyperoxic and hypercarbic gases on tumour blood flow. Br J Cancer , 80, 117-126.
Edmead C, Kanthou C, Benzakour O., 1999. Thrombin activates transcription factors sp1, NF-kappa B, and CREB: importance of the use of phosphatase inhibitors during nuclear protein extraction for the assessment of transcription factor DNA-binding activities., Anal Biochem 275:180-186.
Reyes-Aldasoro, C. C., A. Ganguly, G. Lemus, A. Gupta, "A Hybrid Model Based on Dynamic Programming, Neural Networks and Surrogate Value for Inventory Optimisation Applications", Journal of Operational Research Society (1999) Vol.50, No.1, pp. 85-94.
Reyes-Aldasoro, C. C. "Great Challenge for SatMex: the Future of Mexican Satellites", Compuserve Latinoamérica, August 1998, pp. 6-7.
Reyes-Aldasoro, C. C. "A non-linear decrease rate to optimise the convergence of the Kohonen Neural Network Self-Organising Algorithm." IEEE ROC&C 1999, Acapulco, México, 31 Oct-5 Nov 1999.
Reyes-Aldasoro, C. C. Kuhlmann, F, "Telecommunications and Internet in the Future Society: Myths and Realities." in Computers and Communications, 1999. Proceedings. IEEE International Symposium on, July 1999, Red Sea, Egypt.
Reyes-Aldasoro C. C. "Cyberdensity, Teledensity and Human Development in Mexico and the World" NET@ El medio de las telecomunicaciones Vol. 3, Num. 70, pp.8-9, México D.F., 8 de marzo 1999.
Reyes-Aldasoro, C. C. "Telephony in Mexico: Growth, Distribution and Impact on I.T.", Boletin de Politica Informatica INEGI, No. 6, 1999.
Tozer, G.M., Prise, V.E., Wilson, J., Locke, R.J., Vojnovic, B., Stratford, M.R.L., Dennis, M.F. and Chaplin, D.J., 1999. Combretastatin A-4-phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues. Cancer Res, 59, 1626-1634.
Bell, K., Tozer, G, Poole, B., Prise, V., and Chaplin, D., 1998. Spatial response of the HSN rat tumour to the endothelin B (ETB) receptor agonist IRL 1620: comparison to ETB receptor distribution. Proc. 20th European Conference on Microcirculation. Paris, France, 30 Aug - 2 September 1998, Mundozzi Editore S.p.A. - Bologna, Italy, pp 19-23.
Chaplin, D.J., Hill, S.A., Bell, K.M. and Tozer, G.M, 1998. Modification of tumor blood flow: current status and future directions. Semin Radiat Oncol, 8, 151-163.
Durante, M., Furosawa, Y., George, K., Gialanella, G., Greco, O, Grossi, G., Matsufugi, N., Pugliese, M. and Yang, T. C., 1998. Rejoining and misrejoining of radiation-induced chromatin breaks. IV. Charged particles. Radiat Res, 149, 446-454.
Kanthou C., Kakkar V.V. and Benzakour O., 1998. Cellular and molecular effects of thrombin in the vascular system. In: Angiogenesis. Models, Modulators and Clinical Applications. Edited by M.E. Maragoudakis (Plenum, New York) pp263-282.
Tozer, G.M., Prise, V.E., Motterlini, R., Poole, B.A., Wilson, J. and Chaplin, D.J., 1998. The comparative effects of the NOS inhibitor, N w -nitro-L-arginine, and the haemoxygenase inhibitor, zinc protoporphyrin IX, on tumour blood flow. Int J Radiat Oncol Biol Physics, 42, 849-853.
M. Durante, L. Cella, Y. Furosawa, K. George, G. Gialanella, O. Greco, G. Grossi, M. Pugliese and T.C. Yang. Heavy ions induced chromosomal aberrations analysed by fluorescence in vitro hybridisation. In: GSI Report 97-09, September 1997, G. Kraft and K. Langbein editors. pp. 1-4 (1997)
Lucena, A., C. C. Reyes-Aldasoro, Y. M. Sharaiha, "An Algorithm to Compute Reduced Costs for Spanning Trees", Relatórios de Pesquisa e Desenvolvimento No. 05/95, Laboratório Nacional de Computação Científica- LNCC, Brasil, Maio 1995
|
|
